TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2746-2752

  Sakairi, Toru ^a,b   Abe, Yoshifusa ^a   Kopp, Jeffrey B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FSGS; podocytes; TGF beta1; Wilms' tumor suppressor gene

Indexed keywords

SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILM TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PODOCYTES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; WT1 PROTEINS;

EID: 80053201981     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr061     Document Type: Article

References (36)

1. Kriz W. The pathogenesis of 'classic' focal segmental glomerulosclerosis-lessons from rat models. Nephrol Dial Transplant 2003; 18 (Suppl. 6): vi39-vi44 (Pubitemid 37098593)
2. Barisoni L, Kriz W, Mundel P et al. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999; 10: 51-61 (Pubitemid 29034942)
3. Call KM, Glaser T, Ito CY et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509-520
4. Gessler M, Poustka A, Cavenee W et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774-778
5. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol 2006; 21: 1653-1660 (Pubitemid 44390829)
6. Little M, Wells C. A clinical overview of WT1 gene mutations. Hum Mutat 1997; 9: 209-225 (Pubitemid 27138814)
7. Fischbach BV, Trout KL, Lewis J et al. WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005; 116: 984-988 (Pubitemid 44542829)
8. Kim JH, Kim BK, Moon KC et al. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int 2003; 64: 1715-1721 (Pubitemid 37323700)
9. Moore AW, McInnes L, Kreidberg J et al. YAC complementation shows a requirement for Wt1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999; 126: 1845-1857 (Pubitemid 29240319)
10. Guo JK, Menke AL, Gubler MC et al. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis andmesangial sclerosis. HumMol Genet 2002; 11: 651-659 (Pubitemid 34285136)
11. Bodi I, Kimmel PL, Abraham AA et al. Renal TGF-beta in HIVassociated kidney diseases. Kidney Int 1997; 51: 1568-1577 (Pubitemid 27239913)
12. Bennett MR, Czech KA, Arend LJ et al. Laser capture microdissectionmicroarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp Nephrol 2007; 107: e30-e40 (Pubitemid 47355799)
13. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-16 (Pubitemid 32880291)
14. Lee HS, Song CY. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies. Kidney Blood Press Res 2010; 33: 24-29
15. Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308 (Pubitemid 351282018)
16. Mozes MM, Bottinger EP, Jacot TA et al. Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol 1999; 10: 271-80 (Pubitemid 29068066)
17. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003 (Pubitemid 26182412)
18. Bollig F, Perner B, Besenbeck B et al. A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros. Development 2009; 136: 2883-2892
19. Saleem MA, O'Hare MJ, Reiser J et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638 (Pubitemid 34183927)
20. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-1618 (Pubitemid 34408479)
21. Wrana JL, Attisano L, Carcamo J et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992; 71: 1003-14
22. Han Y, San-Marina S, Yang L et al. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells. Breast Cancer Res 2007; 9: R43
23. Sakairi T, Abe Y, Jat PS et al. Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes. Am J Physiol Renal Physiol 2010; 299: F802-F809
24. Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002; 12: 22-29 (Pubitemid 34094985)
25. Mehra A, Wrana JL. TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol 2002; 80: 605-622 (Pubitemid 36124821)
26. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428 (Pubitemid 46809165)
27. Guo G, Morrison DJ, Licht JD et al. WT1 activates a glomerularspecific enhancer identified from the human nephrin gene. J Am Soc Nephrol 2004; 15: 2851-2856 (Pubitemid 41103394)
28. Berasain C, Herrero JI, Garcia-Trevijano ER et al. Expression ofWilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function. Hepatology 2003; 38: 148-157 (Pubitemid 36775806)
29. Kashikar ND, Reiner J, Datta A et al. Serine threonine receptorassociated protein (STRAP) plays a role in the maintenance of mesenchymal morphology. Cell Signal 2009; 22: 138-149
30. Datta PK, Moses HL. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol 2000; 20: 3157-3167 (Pubitemid 30215028)
31. Scholz H, Bossone SA, Cohen HT et al. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture. J Biol Chem 1997; 272: 32836-32846 (Pubitemid 28023619)
32. Siehl JM, Thiel E, Heufelder K et al. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol 2003; 123: 235-242 (Pubitemid 37305057)
33. Cohen HT, Bossone SA, Zhu G et al. Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 1997; 272: 2901-2913 (Pubitemid 27053340)
34. Dehbi M, Hiscott J, Pelletier J. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB. Oncogene 1998; 16: 2033-2039 (Pubitemid 28211678)
35. Furuhata A, Murakami M, Ito H et al. GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines. Leukemia 2009; 23: 1270-1277
36. Rupprecht HD, Drummond IA, Madden SL et al. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 1994; 269: 6198-6206 (Pubitemid 24243010)